Literature DB >> 17986677

Managing neuropathic pain.

Katherine E Galluzzi1.   

Abstract

Pain may be the most common reason patients seek treatment from physicians. When persistent and unrelieved, pain can frustrate both the person suffering with this condition and the physician trying to alleviate it. Relief from such discomfort may be particularly difficult to achieve and fraught with misconceptions. Treatment usually requires trials of physical, pharmacologic, and surgical interventions to achieve resolution. In cases that remain insoluble, patients must accept partial relief and seek adaptive strategies. Sources of persistent pain may be nociceptive or neuropathic. Both utilize the same nerve pathways for transmission, but significant physiologic differences exist in mechanisms through which these painful stimuli are biologically processed and resolved. Nociceptive pain resulting from a known or obvious source (eg, trauma, cancer metastasis, ischemia, arthritis) is often easy to identify. Neuropathic pain, however, may occur in the absence of an identifiable precipitating cause. Physicians must remain alert to differences in presentation and course of neuropathic pain syndromes, some of which may be subtle or unusual.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17986677

Source DB:  PubMed          Journal:  J Am Osteopath Assoc        ISSN: 0098-6151


  9 in total

1.  New consensus multivariate models based on PLS and ANN studies of sigma-1 receptor antagonists.

Authors:  Aline A Oliveira; Célio F Lipinski; Estevão B Pereira; Kathia M Honorio; Patrícia R Oliveira; Karen C Weber; Roseli A F Romero; Alexsandro G de Sousa; Albérico B F da Silva
Journal:  J Mol Model       Date:  2017-10-02       Impact factor: 1.810

2.  Intrathecal injection of the neurosteroid, DHEAS, produces mechanical allodynia in mice: involvement of spinal sigma-1 and GABA receptors.

Authors:  Seo-Yeon Yoon; Dae-Hyun Roh; Hyoung-Sig Seo; Suk-Yun Kang; Ho-Jae Han; Alvin J Beitz; Jang-Hern Lee
Journal:  Br J Pharmacol       Date:  2009-04-30       Impact factor: 8.739

3.  An evaluation of the antinociceptive effects of Phα1β, a neurotoxin from the spider Phoneutria nigriventer, and ω-conotoxin MVIIA, a cone snail Conus magus toxin, in rat model of inflammatory and neuropathic pain.

Authors:  Alessandra Hubner de Souza; Célio J Castro; Flavia Karine Rigo; Sara Marchesan de Oliveira; Renato Santiago Gomez; Danuza Montijo Diniz; Marcia Helena Borges; Marta Nascimento Cordeiro; Marco Aurélio Romano Silva; Juliano Ferreira; Marcus Vinicius Gomez
Journal:  Cell Mol Neurobiol       Date:  2012-08-07       Impact factor: 5.046

4.  Topical and intranasal analgesic therapy in a woman with refractory postherpetic neuralgia.

Authors:  Kenneth C Hohmeier; Lyndsey M Almon
Journal:  Case Rep Med       Date:  2015-04-09

5.  The effects of vitamin B12 and diclofenac and their combination on cold and mechanical allodynia in a neuropathic pain model in rats.

Authors:  Esmaeal Tamaddonfard; Farzad Samadi; Karim Egdami
Journal:  Vet Res Forum       Date:  2013       Impact factor: 1.054

6.  Reduced GABAergic neuronal activity in zona incerta causes neuropathic pain in a rat sciatic nerve chronic constriction injury model.

Authors:  Hyeong Cheol Moon; Young Seok Park
Journal:  J Pain Res       Date:  2017-05-11       Impact factor: 3.133

7.  Local dermal application of a compound lidocaine cream in pain management of cancer wounds.

Authors:  L Peng; H Y Zheng; Y Dai
Journal:  Braz J Med Biol Res       Date:  2019-11-07       Impact factor: 2.590

Review 8.  Non-opioid pharmacologic treatment of chronic spinal cord injury-related pain.

Authors:  Mendel Kupfer; Christopher S Formal
Journal:  J Spinal Cord Med       Date:  2020-03-17       Impact factor: 1.985

9.  Gabapentin induces edema, hyperesthesia and scaling in a depressed patient; a diagnostic challenge.

Authors:  Reza Bidaki; Zahra Sadeghi; Safiye Shafizadegan; Ali Sadeghi; Behrang Khalili; Alireza Haghshenas; Seyyed Mohammad Mahdy Mirhosseini
Journal:  Adv Biomed Res       Date:  2016-01-27
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.